A case of niraparib PARP-Inhibitor induced Sweet Syndrome in gynecologic cancer
Sweet Syndrome, or acute febrile neutrophilic dermatosis, is a rare inflammatory dermatologic disorder that can be spontaneous, associated with malignancy, or drug-induced. Reports of Sweet Syndrome in gynecologic oncology patients are sparse, and the majority are thought to be malignancy-associated...
Saved in:
Main Authors: | Nora Badiner (Author), Cody Carter (Author), Yevgeniya Ioffe (Author), Linda Hong (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Challenges in PARP inhibitor therapy: A case of Olaparib-induced liver injury and successful rechallenge with Niraparib
by: Kai Zhu, et al.
Published: (2024) -
Searching for the source: Extraovarian primary peritoneal carcinoma presenting as chest wall masses
by: Madison Brinker Feng, et al.
Published: (2023) -
LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring
by: Giovanni Canil, et al.
Published: (2023) -
PARP inhibitor resistance in breast and gynecological cancer: Resistance mechanisms and combination therapy strategies
by: Nannan Wang, et al.
Published: (2022) -
Resistance to PARP-inhibitors in Cancer Therapy
by: Alicia eMontoni, et al.
Published: (2013)